The GLP-1 market for obesity is emerging as a significant driver of expansion within the broad GLP-1 segment
How can patients tell their Ozempic pen is empty
In rare cases, patients have reported musculoskeletal pain or discomfort as a side effect, though this is not common
Refreshing, juice-like taste Blends easily Formulated for everyday hydration No added sugar May be too sweet for some Isn't formulated to support intense exercise Contains stevia, whose aftertaste may not be to everybody's liking Form: Tablet| Serving size: 1 tablet (5 g)| Electrolytes included: Potassium, sodium, calcium, magnesium, chloride| Sodium: 300 mg| Potassium: 150 mg | Carbs: 4 g| Added sugar: 1 g Whether you're on the trail or hitting the pavement, electrolyte tablets can be more convenient than powders especially when they come in a compact tube like Nuun's
Patients with non-alcoholic steatohepatitis (NASH) or non-alcoholic fatty liver disease (NAFLD) with concurrent diabetes or obesity might benefit from the hepatic anti-inflammatory effects observed in clinical studies, though GLP-1 receptor agonists are not yet FDA-approved specifically for liver disease
That gap in data means no responsible recommendation can be made either way